- Home
- DLO vs CRNX Comparison
DLO vs CRNX Comparison
Compare DLO & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLO
- CRNX
- Stock Information
- Founded
- DLO 2013
- CRNX 2008
- Country
- DLO Uruguay
- CRNX United States
- Employees
- DLO N/A
- CRNX N/A
- Industry
- DLO Business Services
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- DLO Consumer Discretionary
- CRNX Health Care
- Exchange
- DLO Nasdaq
- CRNX Nasdaq
- Market Cap
- DLO 3.2B
- CRNX 2.8B
- IPO Year
- DLO 2021
- CRNX 2018
- Fundamental
- Price
- DLO $14.62
- CRNX $30.92
- Analyst Decision
- DLO Buy
- CRNX Strong Buy
- Analyst Count
- DLO 9
- CRNX 7
- Target Price
- DLO $13.18
- CRNX $74.33
- AVG Volume (30 Days)
- DLO 3.1M
- CRNX 1.0M
- Earning Date
- DLO 08-13-2025
- CRNX 08-07-2025
- Dividend Yield
- DLO 3.49%
- CRNX N/A
- EPS Growth
- DLO 9.30
- CRNX N/A
- EPS
- DLO 0.48
- CRNX N/A
- Revenue
- DLO $863,482,000.00
- CRNX $1,392,000.00
- Revenue This Year
- DLO $39.28
- CRNX $489.51
- Revenue Next Year
- DLO $29.45
- CRNX $661.93
- P/E Ratio
- DLO $30.48
- CRNX N/A
- Revenue Growth
- DLO 22.02
- CRNX 0.51
- 52 Week Low
- DLO $7.61
- CRNX $24.10
- 52 Week High
- DLO $16.44
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- DLO 69.00
- CRNX 56.52
- Support Level
- DLO $14.02
- CRNX $28.73
- Resistance Level
- DLO $16.44
- CRNX $31.17
- Average True Range (ATR)
- DLO 0.75
- CRNX 1.44
- MACD
- DLO 0.33
- CRNX 0.25
- Stochastic Oscillator
- DLO 70.74
- CRNX 86.71
About DLO DLocal Limited
DLocal Ltd is focused on making the complex simple, redefining the online payment experience in emerging markets. Through its technology platform, One dLocal, the company enables world-wide enterprise merchants to get paid (pay-in) and to make payments (pay-out) online in a safe and efficient manner. The company earns revenue from fees charged to merchants in connection with payment processing services for cross-border and local payment transactions. The company's geographical segments include Latin America and Non-Latin America with a majority of its revenue being generated from Brazil in Latin America region.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.